While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

Menu
0

While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

0

Your Cart is Empty

Posters

Main menu

Infographics

  • NEW! Connecting Phenotype to Genotype with Functional Gene Screening (View)
  • NEW! CRISPR-Cas: The Next Generation (View)

Scientific Posters

  • "CRISPRa Tools for Gain-of-Function Genetic Screens", ASHG Virtual Meeting, October 2020 (MP4)
  • "Cell Barcoding, Genetic Screens and Expression Profiling at a single-cell level", ASHG Virtual Meeting, October 2020 (MP4)
  • "CRISPRa Tools for Gain-of-Function Genetic Screens", February 2020 (PDF)
  • “Combining Cell Barcoding and CRISPR sgRNA Libraries with Targeted Gene Expression for Single-Cell Genetic Analysis of Tumor Development”, April 2019 (PDF)
  • “Combining Barcode Libraries with Targeted Gene Expression Profiling for Single-Cell Genetic Analysis”, June 2018 (PDF)
  • “CRISPR/Cas9 Genome-Wide sgRNA Libraries for Loss-of-function and Gain-of-function Genetic Screens”, Cell Symposia, October 2017 (PDF)
  • “Profiling of Immunity Biomarkers in Whole Blood”, AACR Annual Meeting, April 2017 (PDF)
  • “CRISPR/Cas9 Genome-Wide gRNA Library for Target Identification”, AACR Annual Meeting, April 2016 (PDF)
  • “Cancer Immunotherapy Biomarker Profiling Assay”, AACR Annual Meeting, April 2016 (PDF)
  • “Cancer ImmuneNet™ Biomarker Profiling Assay”, SITC, November 2015 (PDF)
  • “Loss-of-function genetic screens to find genes regulating cell responses and identify potential drug targets”, EORTC-NCI-AACR 2014 (PDF)
  • “Pooled RNAi Genetic Screening to Identify Functional Genes and Novel Drug Targets”, DOT, October 2013 (PDF)
  • “Pooled RNAi screens in xenograft mouse models”, AACR, April 2013 (PDF)
  • “Identification of potential cancer drug targets in prostate, blood, and breast cancer cells using HT RNAi screening with pooled shRNA libraries”, AACR, April 2011 (PDF)
  • “HT Screening for bioactive peptides that increase radiation tolerance using a pooled lentiviral peptide scanning library”, Gordon Research Conference, Antimicrobial Peptides, May 2011 (email us)
  • “Development of Recombinant Protein Overproducer Cell Lines with Lentiviral Expression Vectors”, IBC 4th Annual Cell Line Development and Engineering Conference, June 2008 (PDF)

For a list of the upcoming events we’re attending, please visit Cellecta’s Events page.